person · Reporting owner

Rittenmeyer Ronald A

Disclosed activity across 5 companies

Tapewire entity: 123368
SEC CIK: 0001210018

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
AMERICAN INTERNATIONAL GROUP, INC.AIG · Entity 3083	Director	April 01, 2019	April 02, 2019
Avaya Holdings Corp.AVYA · Entity 117306	Director	March 15, 2018	March 15, 2018
IQVIA HOLDINGS INC.IQV · Entity 3058	Director	May 11, 2022	May 13, 2022

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

AMERICAN INTERNATIONAL GROUP, INC.

Report date April 01, 2019 · Filed April 02, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Deferred Stock UnitSEC Table II · derivative / convertible security	Direct	19,537	Reported balance After 2019-04-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2019-04-01 · Grant · Acquired 140 · Balance 19,537 F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F2: Reflects deferred stock units previously granted pursuant to the 2010 Plan and the 2013 Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG.

F2: Reflects deferred stock units previously granted pursuant to the 2010 Plan and the 2013 Plan.

Avaya Holdings Corp.

Report date March 15, 2018 · Filed March 15, 2018

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, par value $0.01 per shareSEC Table I · non-derivative	Direct	3,211	Reported balance After 2018-03-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2018-03-15 · Exercise / conversion · Acquired 3,211 · Balance 3,211 F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	9,636	Reported balance After 2018-03-15 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-03-15 · Exercise / conversion · Disposed 3,211 · Balance 9,636 F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP. F2: Represents Restricted Stock Units that have vested as the Common Stock set forth in Table I.

Filing footnotes · ownership attribution and instrument terms

F1: Represents awards of Restricted Stock Units granted on January 23, 2018, pursuant to the Avaya Holdings Corp. 2017 Equity Incentive Plan (the "EIP"), that vest on March 15, 2018. Each Restricted Stock Unit represents a contingent right to receive, at vesting, one share of common stock of Avaya Holdings Corp. Distribution of this common stock will be deferred until the earliest to occur of: (x) December 15, 2020, (y) the recipient's separation of service from the registrant and (z) a "change in control" of the registrant, as defined in the EIP.

F2: Represents Restricted Stock Units that have vested as the Common Stock set forth in Table I.

IQVIA HOLDINGS INC.

Report date May 11, 2022 · Filed May 13, 2022

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	13,533	Reported balance After 2022-05-11 transaction · row 1 1 source row Row 1 · 2022-05-11 · Grant · Acquired 995 · Balance 13,533 F1: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Filing footnotes · ownership attribution and instrument terms

F1: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

IMS Health Holdings, Inc.

Report date October 03, 2016 · Filed October 03, 2016

Section 16 reporting ended · disclosed 2016-10-03. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2016-10-03 transaction · row 1 1 source row Row 1 · 2016-10-03 · Disposition to issuer · Disposed 142,840 · Balance 0 F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc. F2: Disposed of pursuant to merger agreement in exchange for 54,849 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2020-07-20	Direct	Reported balance After 2016-10-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2016-10-03 · Disposition to issuer · Disposed 20,000 · Balance 0 F3: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.80 · Expires 2020-07-20	Direct	Reported balance After 2016-10-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-10-03 · Disposition to issuer · Disposed 10,000 · Balance 0 F4: This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,840 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.
Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.20 · Expires 2020-07-20	Direct	Reported balance After 2016-10-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2016-10-03 · Disposition to issuer · Disposed 20,000 · Balance 0 F5: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.

Filing footnotes · ownership attribution and instrument terms

F1: On May 3, 2016, the issuer and Quintiles Transnational Holdings, Inc. ("Quintiles") entered into an Agreement and Plan of Merger pursuant to which on October 3, 2016 the issuer merged with and into Quintiles (the "merger"), the separate existence of the issuer ceased and Quintiles will continue as the surviving corporation, operating under the name Quintiles IMS Holdings, Inc.

F2: Disposed of pursuant to merger agreement in exchange for 54,849 shares of Quintiles IMS Holdings, Inc. stock having a market value of $81.06 per share at the effective time of the merger.

F3: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $26.05 per share.

F4: This option was assumed by Quintiles in the merger and replaced with an option to purchase 3,840 shares of Quintiles IMS Holdings, Inc. common stock at a price of $15.11 per share.

F5: This option was assumed by Quintiles in the merger and replaced with an option to purchase 7,680 shares of Quintiles IMS Holdings, Inc. common stock at a price of $8.34 per share.

TENET HEALTHCARE CORP

Report date September 30, 2022 · Filed October 04, 2022

Section 16 reporting ended · disclosed 2022-10-04. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	440,235	Reported balance After 2022-09-30 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2022-09-30 · Exercise / conversion · Acquired 32,702 · Balance 440,235 F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	427,366	Reported balance After 2022-09-30 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2022-09-30 · Tax withholding · Disposed 12,869 · Balance 427,366 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
Common StockSEC Table I · non-derivative	Direct	451,018	Reported balance After 2022-09-30 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2022-09-30 · Exercise / conversion · Acquired 23,652 · Balance 451,018 F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	441,710	Reported balance After 2022-09-30 transaction · row 4 Account or security details depend on footnotes; rows are not merged. 1 source row Row 4 · 2022-09-30 · Tax withholding · Disposed 9,308 · Balance 441,710 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
Common StockSEC Table I · non-derivative	Direct	446,593	Reported balance After 2022-09-30 transaction · row 5 Account or security details depend on footnotes; rows are not merged. 1 source row Row 5 · 2022-09-30 · Exercise / conversion · Acquired 4,883 · Balance 446,593 F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments. F2: Restricted stock units convert into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	444,671	Reported balance After 2022-09-30 transaction · row 6 Account or security details depend on footnotes; rows are not merged. 1 source row Row 6 · 2022-09-30 · Tax withholding · Disposed 1,922 · Balance 444,671 F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.
2020 February Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	32,702	Reported balance After 2022-09-30 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2022-09-30 · Exercise / conversion · Disposed 32,702 · Balance 32,702 F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments.
2021 February Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	23,652	Reported balance After 2022-09-30 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2022-09-30 · Exercise / conversion · Disposed 23,652 · Balance 23,652 F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments.
2022 February Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	43,950	Reported balance After 2022-09-30 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2022-09-30 · Exercise / conversion · Disposed 4,883 · Balance 43,950 F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments.
Common StockSEC Table I · non-derivative	IndirectBy spouse	15,000	Reported balance Holding disclosure · report date 2022-09-30 · row 7 Holding and transaction disclosures are not merged. 1 source row Row 7 · Balance 15,000

Filing footnotes · ownership attribution and instrument terms

F1: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 26, 2020, and vest and settle in eleven equal quarterly installments.

F2: Restricted stock units convert into common stock on a one-for-one basis.

F3: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3.

F4: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 24, 2021, and vest and settle in eight equal quarterly installments.

F5: The restricted stock units were granted pursuant to the 2019 Stock Incentive Plan on February 23, 2022, and vest and settle in eleven equal quarterly installments.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 02, 2020 Filed Mar 3, 2020 20:08 UTC	TENET HEALTHCARE CORP THC · Entity 2563	PurchaseCommon Stock	10,000	$27.11	$271,100.00	Disclosure SEC source: 0001209191-20-015035 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,343 F1 · shares: The shares were purchased in open market broker transactions. F2 · price: The price is the weighted average purchase price of the aggregate number of shares that were purchased by the reporting person. These shares were purchased in multiple transactions at prices ranging from $27.06 to $27.12. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document
February 28, 2020 Filed Mar 3, 2020 00:15 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 June Restricted Stock Units · Derivative	7,307	$0.00	$0.00	Disclosure SEC source: 0001209191-20-014809 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,307 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The seventh vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. F4 · derivative.exercise_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The seventh vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. F4 · derivative.expiration_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The seventh vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
February 28, 2020 Filed Mar 3, 2020 00:15 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 March Restricted Stock Units · Derivative	36,083	$0.00	$0.00	Disclosure SEC source: 0001209191-20-014809 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The eighth vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The eighth vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The eighth vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
February 28, 2020 Filed Mar 3, 2020 00:15 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	2,876	$26.28	$75,581.28	Disclosure SEC source: 0001209191-20-014809 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,343 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
February 28, 2020 Filed Mar 3, 2020 00:15 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	7,307	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-014809 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The seventh vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
February 28, 2020 Filed Mar 3, 2020 00:15 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	14,199	$26.28	$373,149.72	Disclosure SEC source: 0001209191-20-014809 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,912 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
February 28, 2020 Filed Mar 3, 2020 00:15 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	36,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-014809 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The eighth vesting date occurred on February 28, 2020, resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
February 26, 2020 Filed Feb 28, 2020 23:23 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Grant2020 February Restricted Stock Units · Derivative	359,713	$0.00	$0.00	Disclosure SEC source: 0001209191-20-014174 · doc4.xml · derivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359,713 Underlying: Common Stock · 359,713 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest and settle in eleven equal quarterly installments on the following dates: June 30, 2020; September 30, 2020; December 31, 2020; March 31, 2021; June 30, 2021; September 30, 2021; December 31, 2021; March 31, 2022; and June 30, 2022; September 30, 2022; and December 31, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest and settle in eleven equal quarterly installments on the following dates: June 30, 2020; September 30, 2020; December 31, 2020; March 31, 2021; June 30, 2021; September 30, 2021; December 31, 2021; March 31, 2022; and June 30, 2022; September 30, 2022; and December 31, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest and settle in eleven equal quarterly installments on the following dates: June 30, 2020; September 30, 2020; December 31, 2020; March 31, 2021; June 30, 2021; September 30, 2021; December 31, 2021; March 31, 2022; and June 30, 2022; September 30, 2022; and December 31, 2022. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
December 31, 2019 Filed Jan 3, 2020 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-20-001184 · doc4.xml · derivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,448 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The third vesting date occurred on December 31, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 377,448 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The third vesting date occurred on December 31, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 377,448 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The third vesting date occurred on December 31, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 377,448 restricted stock units are shown in Table II. F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
December 31, 2019 Filed Jan 3, 2020 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	20,988	$38.03	$798,173.64	Disclosure SEC source: 0001209191-20-001184 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 348,028 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
December 31, 2019 Filed Jan 3, 2020 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-20-001184 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The third vesting date occurred on December 31, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 377,448 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
November 29, 2019 Filed Dec 3, 2019 21:48 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 June Restricted Stock Units · Derivative	7,307	$0.00	$0.00	Disclosure SEC source: 0001209191-19-058728 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,307 Underlying: Common Stock · 7,307 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The sixth vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 7,307 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The sixth vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 7,307 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The sixth vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 7,307 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
November 29, 2019 Filed Dec 3, 2019 21:48 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 March Restricted Stock Units · Derivative	36,083	$0.00	$0.00	Disclosure SEC source: 0001209191-19-058728 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,083 Underlying: Common Stock · 36,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The seventh vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 36,083 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The seventh vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 36,083 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The seventh vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 36,083 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
November 29, 2019 Filed Dec 3, 2019 21:48 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	2,876	$32.20	$92,607.20	Disclosure SEC source: 0001209191-19-058728 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,108 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
November 29, 2019 Filed Dec 3, 2019 21:48 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	7,307	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-058728 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The sixth vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 7,307 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
November 29, 2019 Filed Dec 3, 2019 21:48 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	14,199	$32.20	$457,207.80	Disclosure SEC source: 0001209191-19-058728 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 301,677 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
November 29, 2019 Filed Dec 3, 2019 21:48 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	36,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-058728 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 315,876 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The seventh vesting date occurred on November 29, 2019 (the business day prior to December 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 36,083 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
September 30, 2019 Filed Oct 2, 2019 21:27 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-19-051844 · doc4.xml · derivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,356 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The second vesting date occurred on September 30, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 440,356 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The second vesting date occurred on September 30, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 440,356 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The second vesting date occurred on September 30, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 440,356 restricted stock units are shown in Table II. F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
September 30, 2019 Filed Oct 2, 2019 21:27 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	24,755	$22.12	$547,580.60	Disclosure SEC source: 0001209191-19-051844 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 279,793 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
September 30, 2019 Filed Oct 2, 2019 21:27 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-051844 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The second vesting date occurred on September 30, 2019, resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 440,356 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
August 30, 2019 Filed Sep 4, 2019 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 June Restricted Stock Units · Derivative	7,307	$0.00	$0.00	Disclosure SEC source: 0001209191-19-048305 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,614 Underlying: Common Stock · 7,307 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fifth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 14,614 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fifth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 14,614 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fifth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 14,614 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
August 30, 2019 Filed Sep 4, 2019 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 March Restricted Stock Units · Derivative	36,083	$0.00	$0.00	Disclosure SEC source: 0001209191-19-048305 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,166 Underlying: Common Stock · 36,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The sixth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 72,166 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The sixth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 72,166 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The sixth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 72,166 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
August 30, 2019 Filed Sep 4, 2019 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	2,876	$21.65	$62,265.40	Disclosure SEC source: 0001209191-19-048305 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,640 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
August 30, 2019 Filed Sep 4, 2019 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	7,307	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-048305 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,516 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fifth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 14,614 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
August 30, 2019 Filed Sep 4, 2019 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	14,199	$21.65	$307,408.35	Disclosure SEC source: 0001209191-19-048305 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237,209 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
August 30, 2019 Filed Sep 4, 2019 22:11 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	36,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-048305 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The sixth vesting date occurred on August 30, 2019 (the business day prior to September 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 72,166 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
June 28, 2019 Filed Jul 2, 2019 21:32 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2019 February Restricted Stock Units · Derivative	62,908	$0.00	$0.00	Disclosure SEC source: 0001209191-19-040489 · doc4.xml · derivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 503,264 Underlying: Common Stock · 62,908 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The first vesting date occurred on June 28, 2019 (the business day prior to June 30, 2019, which fell on a weekend), resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 503,264 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The first vesting date occurred on June 28, 2019 (the business day prior to June 30, 2019, which fell on a weekend), resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 503,264 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The first vesting date occurred on June 28, 2019 (the business day prior to June 30, 2019, which fell on a weekend), resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 503,264 restricted stock units are shown in Table II. F4 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
June 28, 2019 Filed Jul 2, 2019 21:32 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	24,755	$20.66	$511,438.30	Disclosure SEC source: 0001209191-19-040489 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,325 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
June 28, 2019 Filed Jul 2, 2019 21:32 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	62,908	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-040489 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on February 27, 2019, the reporting person received a grant of 566,172 time-based restricted stock units that vest and settle in nine equal quarterly installments. The first vesting date occurred on June 28, 2019 (the business day prior to June 30, 2019, which fell on a weekend), resulting in the vesting and settlement of 62,908 shares of common stock, as shown in Table I. The remaining 503,264 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:16 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 June Restricted Stock Units · Derivative	7,307	$0.00	$0.00	Disclosure SEC source: 0001209191-19-034421 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,921 Underlying: Common Stock · 7,307 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fourth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 21,921 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fourth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 21,921 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fourth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 21,921 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:16 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 March Restricted Stock Units · Derivative	36,083	$0.00	$0.00	Disclosure SEC source: 0001209191-19-034421 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,249 Underlying: Common Stock · 36,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fifth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 108,249 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fifth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 108,249 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fifth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 108,249 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:16 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	2,876	$19.96	$57,404.96	Disclosure SEC source: 0001209191-19-034421 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,172 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:16 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	7,307	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-034421 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,048 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The fourth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 7,307 shares of common stock, as shown in Table I. The remaining 21,921 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:16 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	14,199	$19.96	$283,412.04	Disclosure SEC source: 0001209191-19-034421 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,741 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
May 31, 2019 Filed Jun 4, 2019 21:16 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	36,083	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-034421 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,940 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fifth vesting date occurred on May 31, 2019 (the business day prior to June 1, 2019, which fell on a weekend), resulting in the vesting and settlement of 36,083 shares of common stock, as shown in Table I. The remaining 108,249 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
May 16, 2019 Filed May 20, 2019 21:18 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	GrantCommon Stock	1,478	$0.00	$0.00	Disclosure SEC source: 0001478242-19-000031 · edgar.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,785 F1 · shares: Shares acquired from award of IQVIA Holdings Inc. common stock for Non-Employee Directors that are fully vested upon grant. Read SEC document
April 01, 2019 Filed Apr 2, 2019 20:57 UTC	AMERICAN INTERNATIONAL GROUP, INC. AIG · Entity 3083	GrantDeferred Stock Unit · Derivative	140	Not disclosed	Not disclosed	Disclosure SEC source: 0001225208-19-006152 · doc4.xml · derivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,537 Underlying: Common Stock · 140 shares Expires not disclosed F1 · derivative.exercise_price: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F1 · shares: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F1 · price: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F1 · derivative.exercise_date: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F1 · derivative.expiration_date: Dividend equivalent in the form of deferred stock units with respect to deferred stock units previously awarded under the American International Group, Inc. ("AIG") 2010 Stock Incentive Plan (the "2010 Plan") and the AIG 2013 Omnibus Incentive Plan (the "2013 Plan"). Subject to the terms of the 2010 Plan and the 2013 Plan, respectively, and the related award agreement, shares of AIG Common Stock underlying the deferred stock units will be deliverable, without any cash consideration or conditions, on the last trading day of the month in which the director ceases to be a director of AIG. F2 · balance_after: Reflects deferred stock units previously granted pursuant to the 2010 Plan and the 2013 Plan. Read SEC document
March 01, 2019 Filed Mar 4, 2019 23:41 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 June Restricted Stock Units · Derivative	7,306	$0.00	$0.00	Disclosure SEC source: 0001209191-19-015948 · doc4.xml · derivative · entry 7 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,228 Underlying: Common Stock · 7,306 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The third vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 29,228 restricted stock units are shown in Table II. F4 · derivative.exercise_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The third vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 29,228 restricted stock units are shown in Table II. F4 · derivative.expiration_date: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The third vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 29,228 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
March 01, 2019 Filed Mar 4, 2019 23:41 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversion2018 March Restricted Stock Units · Derivative	36,082	$0.00	$0.00	Disclosure SEC source: 0001209191-19-015948 · doc4.xml · derivative · entry 6 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,332 Underlying: Common Stock · 36,082 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fourth vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 144,332 restricted stock units are shown in Table II. F1 · derivative.exercise_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fourth vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 144,332 restricted stock units are shown in Table II. F1 · derivative.expiration_date: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fourth vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 144,332 restricted stock units are shown in Table II. F5 · derivative.underlying: Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
March 01, 2019 Filed Mar 4, 2019 23:41 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	1,775	$29.39	$52,167.25	Disclosure SEC source: 0001209191-19-015948 · doc4.xml · nonDerivative · entry 4 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,857 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
March 01, 2019 Filed Mar 4, 2019 23:41 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	7,306	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-015948 · doc4.xml · nonDerivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: As previously reported, on June 29, 2018, the reporting person received a grant of 51,146 time-based restricted stock units that vest and settle in seven equal quarterly installments. The third vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 7,306 shares of common stock, as shown in Table I. The remaining 29,228 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
March 01, 2019 Filed Mar 4, 2019 23:41 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Tax withholdingCommon Stock	10,191	$29.39	$299,513.49	Disclosure SEC source: 0001209191-19-015948 · doc4.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,326 F3 · shares: Shares withheld for payment of taxes upon vesting of restricted stock units in accordance with Rule 16b-3. Read SEC document
March 01, 2019 Filed Mar 4, 2019 23:41 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Exercise / conversionCommon Stock	36,082	Not disclosed	Not disclosed	Disclosure SEC source: 0001209191-19-015948 · doc4.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 155,517 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: As previously reported, on March 29, 2018, the reporting person received a grant of 288,660 time-based restricted stock units that vest and settle in eight equal quarterly installments. The fourth vesting date occurred on March 1, 2019, resulting in the vesting and settlement of 36,082 shares of common stock, as shown in Table I. The remaining 144,332 restricted stock units are shown in Table II. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document
February 27, 2019 Filed Mar 1, 2019 22:53 UTC	TENET HEALTHCARE CORP THC · Entity 2563	Grant2019 February Restricted Stock Units · Derivative	566,172	$0.00	$0.00	Disclosure SEC source: 0001209191-19-015141 · doc4.xml · derivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director · Executive Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 566,172 Underlying: Common Stock · 566,172 shares Expires not disclosed F1 · derivative.exercise_price: These time-based restricted stock units vest and settle in nine equal quarterly installments on the following dates: June 30, 2019; September 30, 2019; December 31, 2019; March 31, 2020; June 30, 2020; September 30, 2020; December 31, 2020; March 31, 2021; and June 30, 2021. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.exercise_date: These time-based restricted stock units vest and settle in nine equal quarterly installments on the following dates: June 30, 2019; September 30, 2019; December 31, 2019; March 31, 2020; June 30, 2020; September 30, 2020; December 31, 2020; March 31, 2021; and June 30, 2021. Restricted stock units are settled in shares of the Company's common stock upon vesting. F1 · derivative.expiration_date: These time-based restricted stock units vest and settle in nine equal quarterly installments on the following dates: June 30, 2019; September 30, 2019; December 31, 2019; March 31, 2020; June 30, 2020; September 30, 2020; December 31, 2020; March 31, 2021; and June 30, 2021. Restricted stock units are settled in shares of the Company's common stock upon vesting. Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:34 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	7,680	$0.00 Strike: $26.05	$0.00	Disclosure SEC source: 0001478242-19-000016 · edgar.xml · derivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,680 shares Expires 2020-07-20 Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:34 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	7,680	$138.00	$1,059,840.00	Disclosure SEC source: 0001478242-19-000016 · edgar.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,307 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018. F2 · price: The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $136.00 to $140.00 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document
February 14, 2019 Filed Feb 19, 2019 22:34 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherCommon Stock	7,680	$26.05	$200,064.00	Disclosure SEC source: 0001478242-19-000016 · edgar.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,987 Read SEC document
February 05, 2019 Filed Feb 7, 2019 22:05 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherEmployee Stock Option (Right to Buy) · Derivative	3,840	$0.00 Strike: $15.11	$0.00	Disclosure SEC source: 0001478242-19-000006 · edgar.xml · derivative · entry 3 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,840 shares Expires 2020-07-20 Read SEC document
February 05, 2019 Filed Feb 7, 2019 22:05 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	SaleCommon Stock	3,840	$130.00	$499,200.00	Disclosure SEC source: 0001478242-19-000006 · edgar.xml · nonDerivative · entry 2 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,307 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018. Read SEC document
February 05, 2019 Filed Feb 7, 2019 22:05 UTC	IQVIA HOLDINGS INC. IQV · Entity 3058	OtherCommon Stock	3,840	$15.11	$58,022.40	Disclosure SEC source: 0001478242-19-000006 · edgar.xml · nonDerivative · entry 1 Rittenmeyer Ronald A · CIK 0001210018 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,147 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.